Bio
Kevin (Shih-Hsien) Liu is an experienced research scientist in computational chemistry focusing on biomolecular modeling and simulation.
Professional Experience
University of Tennessee / Oak Ridge National Laboratory
Center for Molecular Biophysics
I have led the following scientific projects funded by organizations in parentheses in this role:
7. Designing reversible covalent inhibitors to key enzyme protein in cancer (BPGbio, Inc.), 2024-Present
6. Designing noncovalent inhibitors to AdeB membrane protein in Acinetobacter baumannii bacterium (NIH), 2024-Present
5. Identified structure-activity relationship in M surface protein for group A Streptococcal infection vaccine (NIH), 2021-2023
4. Identified potent inhibitors to RNA-dependent RNA polymerase in SARS-CoV-2 for COVID-19 (NIH), 2021-2023
3. Identified potent media to reduce energy consumption in production of biopolymer composite for 3D printing (DOE), 2019-2021
2. Identified potent inhibitors to fibroblast growth factor 23-alpha-klotho protein-protein interactions in kidney disease (NIH), 2018-2020
1. Identified potent inhibitors to Candidatus Liberibacter asiaticus bacterium for citrus greening disease (USDA), 2017-2019
Education
Ph.D., Computational Chemistry, the Pennsylvania State University, 2011-2017
M.S., Materials Chemistry, National Taiwan University, 2008-2010
B.S.E., Chemical Engineering, National Taiwan University, 2004-2008